Ethex Corp recalls five generic products that pose life-threatening overdose risk
Ethex Corp and FDA notified healthcare professionals of a voluntary recall of five generic products:
- Propafenone HCl Tablets
- Isosorbide Mononitrate Extended Release Tablets
- Morphine Sulfate Extended Release Tablets
- Morphine Sulfate Immediate Release Tablets
- Dextroamphetamine Sulfate Tablets
The products were recalled because they may contain oversized tablets. Oversized tablets may contain more than the intended levels of the active drug ingredient that could result in patients receiving as much as twice the expected dosage of these drugs, which could cause serious or life-threatening consequences.
Overdoses can include arrhythmias and low blood pressure with Propafenone HCl; fainting and low blood pressure with Isosorbide Mononitrate; respiratory depression and low blood pressure with Morphine Sulfate; and rapid heart rate and high blood pressure with Dextroamphetamine Sulfate. Patients who experience any adverse reactions to these drugs should contact their healthcare professional immediately. See the manufacturer's drug recall notice for specific lot numbers of the products affected by this recall.
The side effects associated with these dangerous drugs are serious and life threatening. Consumers who experience any adverse reactions to these drugs should contact their physician and/or healthcare provider immediately. If you are a loved one have been serious injured by one of these defective pharmaceutical drugs, you should contact a medical injury lawyer to learn more about your options for claiming compensation you may be due.
